Soo Chin Lee - Concepedia

Author

Soo Chin Lee

Also Known As

Bachelot, Thomas, Barbara J Perkins, Gao, Yu-Tang, Lee, Soo Chin, Lee, Soo-Chin, S.C. Lee, S.C. Lee, Sara H. Olson, Soo Chin Lee, Soo, R.-A.

364

Publications

12.4K

Citations

H-Index

114

Concepts

All Affiliations

National University of Singapore National University Cancer Institute, Singapore National University Health System National University Hospital National Cancer Centre Singapore

About

Soo Chin Lee is an author at National University of Singapore specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	38	3.1K
2	Health Sciences	7	7	991
3	Engineering	2	2	316
4	Natural Sciences	2	2	107
5	Language Studies	1	1	146

Soo Chin Lee

127

Publications

Citations

H-Index

Page 1

	Year	Citations
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study Sandra M. Swain, David Miles, Sung‐Bae Kim, The Lancet Oncology End-of-study ResultsBreast OncologyMedicineClinical TrialsPathology	2020	854
Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells Majid Ebrahimi Warkiani, Guofeng Guan, Khoo Bee Luan, Lab on a Chip	2013	573
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer L.S. Ong, Wee Chyan Lee, Shijun Ma, Proceedings of the National Academy of Sciences	2022	565
The genomic landscape of nasopharyngeal carcinoma De‐Chen Lin, Xuan Meng, Masaharu Hazawa, Nature Genetics Tumor HeterogeneityGenomic LandscapeNasopharyngeal CancerPathologyCancer Genomics	2014	370
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer Ahmad Awada, Rámón Colomer, Kenichi Inoue, JAMA Oncology	2016	310
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial Ian E. Krop, Ingrid A. Mayer, Vinod Ganju, The Lancet Oncology Metastatic Breast CancerOncologyBreast OncologyMedicineAromatase	2016	288
Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies Boon-Cher Goh, Soo Chin Lee, Lingzhi Wang, Journal of Clinical Oncology	2002	269
Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells Bee Luan Khoo, Majid Ebrahimi Warkiani, Daniel Shao-Weng Tan, PLoS ONE	2014	202
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer Carlos H. Barrios, Mei-Ching Liu, Soo Chin Lee, Breast Cancer Research and Treatment	2010	196
An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells Majid Ebrahimi Warkiani, Bee Luan Khoo, Daniel Shao-Weng Tan, The Analyst	2014	188

Page 1